STAAR Surgical Opens 30-Day Window for Higher Bids Than Alcon Deal

STAAR Surgical Company has amended its merger agreement with Alcon to open a 30-day go-shop period. The move allows STAAR to actively seek alternative takeover proposals without Alcon's matching rights, disclosure restrictions, or termination fees. The goal is to maximize shareholder value based on STAAR's recent results. The Alcon merger shareholder vote has been rescheduled for December 19. STAAR's stock is trading at $25.60, down 3.87%.